Trials / Unknown
UnknownNCT03322176
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk-Reducing, and Preventative Strategies Using LYNCH Genetic Testing
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Data Collection Analysis Business Management · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Increase surveillance for LYNCH Syndrome
Detailed description
The purpose of this minimal risk, observational survey is to increase surveillance for Lynch Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to determine targeted risk-reducing and preventative strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Genetic testing | LYNCH genetic testing |
Timeline
- Start date
- 2017-10-17
- Primary completion
- 2020-10-17
- Completion
- 2020-11-01
- First posted
- 2017-10-26
- Last updated
- 2019-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03322176. Inclusion in this directory is not an endorsement.